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e thank Dr. Rassi (1) for his interest in our study (2) and the
pportunity to highlight some points that were possibly not
ufficiently highlighted in the original publication. The prog-
ostic value of coronary computed tomographic angiography
CTA) in our study was established based on the significant
ifference observed regarding the composite end point of
ardiac death, myocardial infarction, and rehospitalization for
nstable angina. The majority of cardiologists will agree that,
lthough on a different degree, each of these is an important
dverse event that should be prevented. A large number of
rials have chosen this combination as a primary end point
hen comparing various drugs or treatment strategies. The
esults of our study are further strengthened by the observation
f a significant difference in respect to all cause mortality (see
able 2 in our study [2]). This is a relevant finding considering
ur limited ability to precisely define the cause of death.
Many colleagues will agree that an ischemia driven revas-
ularization procedure is also an important adverse event.
ngina pectoris causes considerable morbidity and coronary
evascularization is a well proven symptomatic therapy, it may
ven improve survival (3). The difference found in our study
egarding this outcome can only reinforce the overall message
bout the prognostic value of CTA.
Regarding Dr. Rassi’s last point, we agree that our study
opulation does not completely match the asymptomatic
ramingham population (3). Nevertheless, not taking into
ccount current cardiac symptoms (as does the Framingham
lgorithm [4]) will rather underestimate the patient risk, and
he difference in the definition of adverse events of interest
ostly reflects the progress of diagnosis and treatment oforonary artery disease since the 1970s and 1980s. Even so, all
bserved adverse events of our study met the end point criteria
f the original Framingham study (5). Therefore we believe it
s adequate to use this well established score to demonstrate
hat the event rate after normal CTA is lower than predicted
y conventional risk factors.
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